Meta-analysis design and results in real life: Problem solvers or detour to maze. A critical review of meta-analysis of DAPT randomized controlled trials

Ivan J. Núñez Gil, Ainhoa Elizondo, Simona Gradari, Pedro A. Villablanca, Hector Bueno, Gisela Feltes, Alicia Quirós, Harish Ramakrishna, Louka Boshra, Antonio Fernandez-Ortiz

Research output: Contribution to journalArticle

Abstract

Background: Therapeutic strategies - such as duration of dual antiplatelet therapy after coronary artery stenting - usually generate a large quantity of meta-analyses. The meta-analyses that include the same randomized clinical trials should produce similar results. Our aim in the study is to analyze the quality and to compare the results of meta-analyses focused on a controversial topic such as dual antiplatelet therapy after percutaneous coronary intervention. Methods: We searched all published meta-analyses published up to November 2015 (near DAPT trial publication) selecting those that included the same randomized clinical trials comparing patterns of briefer versus longer–term double antiplatelet therapy. Results: Seventeen meta-analyses achieved our selection criteria. Of the seventeen analyzed, we identified seven (41.1%) based on the same ten randomized clinical trials (RCTs), yet their results varied widely. Many of the meta-analyses differed in only some minor aspect of the design (i.e. eligible studies, length of comparators and statistical methods used). Some authors differed in the number of patients participating in RCTs and even, despite reviewing the same underlying trials, only 2 of the 7 meta-analyses included the same number of patients. Conclusion: Meta-analyses around cardiovascular, all-cause or non-cardiovascular death differ frequently. In the DAPT duration setting, several meta-analyses have been recently published based on the same data, presenting several issues making it difficult to determine clear recommendations on certain points.

Original languageEnglish (US)
JournalCardiovascular Revascularization Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Meta-Analysis
Randomized Controlled Trials
Percutaneous Coronary Intervention
Therapeutics
Patient Selection
Publications
Coronary Vessels

Keywords

  • Dual antiplatelet therapy
  • Meta-analyses
  • Meta-analysis
  • Methods
  • Percutaneous coronary intervention
  • Statistics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Meta-analysis design and results in real life : Problem solvers or detour to maze. A critical review of meta-analysis of DAPT randomized controlled trials. / Núñez Gil, Ivan J.; Elizondo, Ainhoa; Gradari, Simona; Villablanca, Pedro A.; Bueno, Hector; Feltes, Gisela; Quirós, Alicia; Ramakrishna, Harish; Boshra, Louka; Fernandez-Ortiz, Antonio.

In: Cardiovascular Revascularization Medicine, 01.01.2018.

Research output: Contribution to journalArticle

Núñez Gil, Ivan J. ; Elizondo, Ainhoa ; Gradari, Simona ; Villablanca, Pedro A. ; Bueno, Hector ; Feltes, Gisela ; Quirós, Alicia ; Ramakrishna, Harish ; Boshra, Louka ; Fernandez-Ortiz, Antonio. / Meta-analysis design and results in real life : Problem solvers or detour to maze. A critical review of meta-analysis of DAPT randomized controlled trials. In: Cardiovascular Revascularization Medicine. 2018.
@article{d73f12e6d15d47ad807f8f8d53821d73,
title = "Meta-analysis design and results in real life: Problem solvers or detour to maze. A critical review of meta-analysis of DAPT randomized controlled trials",
abstract = "Background: Therapeutic strategies - such as duration of dual antiplatelet therapy after coronary artery stenting - usually generate a large quantity of meta-analyses. The meta-analyses that include the same randomized clinical trials should produce similar results. Our aim in the study is to analyze the quality and to compare the results of meta-analyses focused on a controversial topic such as dual antiplatelet therapy after percutaneous coronary intervention. Methods: We searched all published meta-analyses published up to November 2015 (near DAPT trial publication) selecting those that included the same randomized clinical trials comparing patterns of briefer versus longer–term double antiplatelet therapy. Results: Seventeen meta-analyses achieved our selection criteria. Of the seventeen analyzed, we identified seven (41.1{\%}) based on the same ten randomized clinical trials (RCTs), yet their results varied widely. Many of the meta-analyses differed in only some minor aspect of the design (i.e. eligible studies, length of comparators and statistical methods used). Some authors differed in the number of patients participating in RCTs and even, despite reviewing the same underlying trials, only 2 of the 7 meta-analyses included the same number of patients. Conclusion: Meta-analyses around cardiovascular, all-cause or non-cardiovascular death differ frequently. In the DAPT duration setting, several meta-analyses have been recently published based on the same data, presenting several issues making it difficult to determine clear recommendations on certain points.",
keywords = "Dual antiplatelet therapy, Meta-analyses, Meta-analysis, Methods, Percutaneous coronary intervention, Statistics",
author = "{N{\'u}{\~n}ez Gil}, {Ivan J.} and Ainhoa Elizondo and Simona Gradari and Villablanca, {Pedro A.} and Hector Bueno and Gisela Feltes and Alicia Quir{\'o}s and Harish Ramakrishna and Louka Boshra and Antonio Fernandez-Ortiz",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.carrev.2018.10.021",
language = "English (US)",
journal = "Cardiovascular Revascularization Medicine",
issn = "1553-8389",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Meta-analysis design and results in real life

T2 - Problem solvers or detour to maze. A critical review of meta-analysis of DAPT randomized controlled trials

AU - Núñez Gil, Ivan J.

AU - Elizondo, Ainhoa

AU - Gradari, Simona

AU - Villablanca, Pedro A.

AU - Bueno, Hector

AU - Feltes, Gisela

AU - Quirós, Alicia

AU - Ramakrishna, Harish

AU - Boshra, Louka

AU - Fernandez-Ortiz, Antonio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Therapeutic strategies - such as duration of dual antiplatelet therapy after coronary artery stenting - usually generate a large quantity of meta-analyses. The meta-analyses that include the same randomized clinical trials should produce similar results. Our aim in the study is to analyze the quality and to compare the results of meta-analyses focused on a controversial topic such as dual antiplatelet therapy after percutaneous coronary intervention. Methods: We searched all published meta-analyses published up to November 2015 (near DAPT trial publication) selecting those that included the same randomized clinical trials comparing patterns of briefer versus longer–term double antiplatelet therapy. Results: Seventeen meta-analyses achieved our selection criteria. Of the seventeen analyzed, we identified seven (41.1%) based on the same ten randomized clinical trials (RCTs), yet their results varied widely. Many of the meta-analyses differed in only some minor aspect of the design (i.e. eligible studies, length of comparators and statistical methods used). Some authors differed in the number of patients participating in RCTs and even, despite reviewing the same underlying trials, only 2 of the 7 meta-analyses included the same number of patients. Conclusion: Meta-analyses around cardiovascular, all-cause or non-cardiovascular death differ frequently. In the DAPT duration setting, several meta-analyses have been recently published based on the same data, presenting several issues making it difficult to determine clear recommendations on certain points.

AB - Background: Therapeutic strategies - such as duration of dual antiplatelet therapy after coronary artery stenting - usually generate a large quantity of meta-analyses. The meta-analyses that include the same randomized clinical trials should produce similar results. Our aim in the study is to analyze the quality and to compare the results of meta-analyses focused on a controversial topic such as dual antiplatelet therapy after percutaneous coronary intervention. Methods: We searched all published meta-analyses published up to November 2015 (near DAPT trial publication) selecting those that included the same randomized clinical trials comparing patterns of briefer versus longer–term double antiplatelet therapy. Results: Seventeen meta-analyses achieved our selection criteria. Of the seventeen analyzed, we identified seven (41.1%) based on the same ten randomized clinical trials (RCTs), yet their results varied widely. Many of the meta-analyses differed in only some minor aspect of the design (i.e. eligible studies, length of comparators and statistical methods used). Some authors differed in the number of patients participating in RCTs and even, despite reviewing the same underlying trials, only 2 of the 7 meta-analyses included the same number of patients. Conclusion: Meta-analyses around cardiovascular, all-cause or non-cardiovascular death differ frequently. In the DAPT duration setting, several meta-analyses have been recently published based on the same data, presenting several issues making it difficult to determine clear recommendations on certain points.

KW - Dual antiplatelet therapy

KW - Meta-analyses

KW - Meta-analysis

KW - Methods

KW - Percutaneous coronary intervention

KW - Statistics

UR - http://www.scopus.com/inward/record.url?scp=85057799384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057799384&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2018.10.021

DO - 10.1016/j.carrev.2018.10.021

M3 - Article

AN - SCOPUS:85057799384

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

SN - 1553-8389

ER -